Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 | --- | --- | |----------------------------------------------------------------------------------------------- ...

DarioHealth Corp. (NASDAQ:DRIO) Q4 2021 Earnings Conference Call March 22, 2022 8:30 AM ET Company Participants Glenn Garmont – Investor Relations Erez Raphael – Chief Executive Officer Rick Anderson – President and General Manager-North America Zvi Ben-David – Chief Financial Officer Conference Call Participants Alex Nowak – Craig Hallam Craig Jones – Stifel Operator Greetings, and welcome to the DarioHealth Corporation Fourth Quarter 2021 Results Conference Call. At this time all participants are in a lis ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________to________________ Commission File No. 001-37704 DARIOHEALTH CORP. (Exact name of registrant as specified in its charter) Delaware 45-297316 ...

DarioHealth Corp. (NASDAQ:DRIO) Q3 2021 Earnings Conference Call November 16, 2021 8:30 AM ET Company Participants Glenn Garmont - Investor Relations Erez Raphael - Chief Executive Officer Zvi Ben-David - Chief Financial Officer Rick Anderson - President and General Manager, North America Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Charles Rhyee - Cowen and Compay David Grossman - Stifel Nathan Weinstein - Aegis Capital Ben Haynor - Alliance Global Partners Operator Greetings and we ...

Table of Contents ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 | --- | --- | |-------------------------------------------------------------------------------------------------|-----------------------| | (Exact name of registrant as specified in its charter) \nDe ...

DarioHealth Corp. (NASDAQ:DRIO) Q2 2021 Earnings Conference Call August 16, 2021 8:30 AM ET Company Participants Chuck Padala - Investor Relations Erez Raphael - Chief Executive Officer Zvi Ben-David - Chief Financial Officer Rick Anderson - President and General Manager, North America Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Charles Rhyee - Cowen David Grossman - Stifel Ben Haynor - Alliance Global Partners Operator Greetings and welcome to the DarioHealth Corporation’s Second Q ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 | --- | --- | |------------------------------------------------------------------------------------------------ ...

DarioHealth Corp. (NASDAQ:DRIO) Q1 2021 Earnings Conference Call May 18, 2021 8:30 AM ET Company Participants Glenn Garmont - Investor Relations Erez Raphael - Chief Executive Officer Zvi Ben-David - Chief Financial Officer Rick Anderson - President and General Manager, North America Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Charles Rhyee - Cowen David Grossman - Stifel Joe Downing - Cantor Fitzgerald Nathan Weinstein - Aegis Capital Operator Greetings and welcome to the DarioHeal ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 DarioHealth Corp. (Exact name of registrant as specified in its charter) Delaware 45-2973162 (State or other j ...

DarioHealth Corp. (NASDAQ:DRIO) Q4 2020 Earnings Conference Call March 9, 2021 8:30 AM ET Company Participants Glenn Garmont - Managing Director, Life Sci Advisors Erez Raphael - President and Chief Executive Officer Zvi Ben-David - Chief Financial Officer Rick Anderson - President, General Manager, North America Conference Call Participants Alex Nowak - Craig-Hallum Charles Rhyee - Cowen and Company Steve Halper - Cantor Fitzgerald David Grossman - Stifel Nathan Weinstein - Aegis Capital Operator Greetings ...